U.S. FDA Approves New MENTOR ® MemoryGel BOOST™ Breast Implant

Irvine, Calif., (January 13, 2021) – Mentor Worldwide LLC, the number one global brand in breast aesthetics, and part of the Johnson &Johnson Medical Devices Companies** today announced that the U.S. Food and Drug Administration (FDA) approved the MENTOR® MemoryGel BOOST™ Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction. This product will be commercially available for surgeons in the United States in early 2022. Nearly 400,000 women undergo breast implant surgeries every year in the U.S.[1], and selecting an implant is a very personal decision and critical part of the journey. Each patient’s preferences and goals are unique, and that means providing surgeons with a wide range of sizes and profiles to enhance their ability to individualize a patient’s results. While there are many options currently available, surgeons cite the need for an implant with increased form stability to help shape the breast, without sacrificing the soft, natural feel that patients desire. “Our commitment to innovation is driven, first and foremost, by the needs of our customers and patients, and providing them with the highest quality products to achieve their desired outcome,” said Lori Tierney, Worldwide President, Mentor Worldwide LLC. “With this pivotal addition to our MemoryGel® portfolio, we are thrilled to provide a meaningful range of options to meet surgeon o...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Latest News Source Type: news

Related Links:

Purpose: To report the long-term outcomes after phototherapeutic keratectomy (PTK) for the treatment of bullous keratopathy. Methods: This is a retrospective medical record review of all patients with symptomatic bullous keratopathy who underwent PTK between June 2005 and March 2019 at the Royal Victorian Eye and Ear Hospital who were followed up for at least 12 months after the procedure. Medical records were used to extract demographic data, etiology of bullous keratopathy, complication rates, and subsequent procedures after PTK. The main outcomes recorded were pain and recurrence of bullae, which were assesse...
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
Purpose: The purpose of this article was to study the clinical, optical, and morphological correlates of visual function in patients with Fuchs endothelial corneal dystrophy (FECD). Methods: The case records were analyzed for patients diagnosed with FECD between September 2019 and March 2020. The best-corrected visual acuity (BCVA) was recorded as decimal visual acuity and converted to the logarithm of the minimum angle of resolution units. Contrast sensitivity was measured with the Pelli–Robson contrast sensitivity test. Corneal alterations, including central corneal thickness, depression of the posterior...
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
Conclusions: Using the new 6-mm cylindrical light guide for IPL treatment in patients with MGD induced less pain during treatment and had similar treatment effects to the conventional 8 × 15-mm light guide. The new 6-mm cylindrical light guide can be useful when treating patients with dark or hyperpigmented skin and for pediatric patients with low compliance.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
Conclusions: The overall prevalence of SARS-CoV-2 was 1% (2% for conjunctival and 0% for corneal samples, P value = 0.5) in the donors who were found suitable for cornea recovery and transplantation. The findings of exceptionally low positive rates in our samples validate the criticality of history-based donor screening and do not support the necessity of postmortem PCR testing as a criterion for procurement and subsequent use for corneal transplantation.
Source: Cornea - Category: Opthalmology Tags: Basic Investigation Source Type: research
Abstract: The Rho kinase inhibitor netarsudil is a recently approved therapeutic option for the management of increased intraocular pressure in the United States. Although phase 3 clinical trials noted corneal changes related to the medication—namely, nonvisually-significant corneal verticillata—descriptions of a unique form of cystic epithelial edema began to surface as netarsudil (and its sister drug ripasudil, approved in Japan) gained widespread use. This series adds 3 new cases and reviews the current literature on this unique side effect.
Source: Cornea - Category: Opthalmology Tags: Case Report Source Type: research
Conclusions: To the best of our knowledge, this case of full-thickness graft rejection after the Moderna SARS-CoV-2 mRNA vaccination is the first to be reported worldwide. The temporal relationship between vaccination and subsequent rejection is highly suggestive of causation due to the short interval (3 days) between vaccination and rejection and the lack of other inciting factors in an otherwise healthy graft. Patients with corneal transplants who plan to take the COVID-19 vaccinations should be counseled on symptoms and closely monitored, and an individualized plan should be made in discussion with the ophthalmologist.
Source: Cornea - Category: Opthalmology Tags: Case Report Source Type: research
According to the American  Association of Colleges of Nursing (2020b) (AACN), the nursing shortage in the United States (U.S.) is critical and remains a growing concern as baby boomers near retirement. To further compound this issue, nursing schools are failing to meet increasing enrollment demands due to nationwide nursin g faculty shortages (AACN, 2020a). Despite efforts to increase enrollment, approximately 75,000 qualified students are denied admission to nursing school each year and many nursing schools are running at full or over capacity despite constraints of both limited faculty and clinical sites (AACN, 20 20b).
Source: Clinical Simulation in Nursing - Category: Nursing Authors: Source Type: research
Conclusions: CHEU experienced increased odds of hospitalization relative to CHUU. A substantial number of CHEU hospitalizations occurred within the neonatal period and were ICU admissions. Initiating ART preconception may reduce the risk of infection-related hospitalizations. These findings reinforce the benefit of ART in pregnancy and the need for ongoing pediatric care to reduce hospitalizations.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: HIV Reports Source Type: research
Background: The relationship of early catheter-related bloodstream infections (CRBSIs) with perioperative neutropenia and antibiotic prophylaxis is not well established. We sought to evaluate perioperative factors associated with early CRBSIs in newly diagnosed pediatric cancer patients, particularly hematologic indices and antibiotic use. Methods: We retrospectively reviewed national registry records of newly diagnosed pediatric cancer patients with port-a-caths inserted using standardized perioperative protocols where only antibiotic use was not regulated. Thirty-day postoperative CRBSI incidence was correlate...
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Immunology and Host Response Source Type: research
Conclusions: There is significant variability in the presentation of coccidioidomycosis in the neonatal period, and diagnosis may be challenging. In endemic regions, healthcare providers should consider coccidioidomycosis in their differential diagnoses of ill-appearing neonates that do not respond to treatment.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Maternal-Neonatal Reports Source Type: research
More News: Allergy | Autoimmune Disease | Breast Augmentation | Breast Surgery | Breastfed | Cancer | Cancer & Oncology | Chronic Fatigue Syndrome | Chronic Pain | Depression | Education | Food and Drug Administration (FDA) | Health Management | Legislation | Lupus | Lymphoma | Medical Devices | Men | Milk | Nursing | Orthopaedics | Pain | Pharmaceuticals | Plastic Surgery | Pregnancy | Science | Scleroderma | Statistics | USA Health | Warnings | Women